作者: Desmond Mascarenhas
DOI:
关键词: Disease 、 In vivo 、 Sensitization 、 Binding protein 、 Pharmacology 、 Medicine 、 Human disease
摘要: New methods for the treatment of human disease are provided. IGFBP-3 is administered together with a co-administered agent to subjects having disease, thereby alleviating symptoms under conditions where administration alone at maximum practicable dose has no measurable beneficial effect on condition.